Vivitrol is a monthly naltrexone injection approved by the FDA to treat both alcohol use disorder and opioid addiction. This extended-release medication works by blocking opioid receptors in the brain, reducing cravings and preventing the euphoric effects of alcohol and opioids. Unlike daily oral medications, the vivitrol naltrexone injection is administered once per month by a healthcare provider, eliminating concerns about daily medication compliance and offering a reliable foundation for recovery.

For individuals struggling with alcohol dependency or opioid addiction, Vivitrol represents a significant advancement in medication-assisted treatment. By providing consistent therapeutic levels of naltrexone for 30 days, this injection can help reduce the risk of relapse while individuals focus on building recovery skills through therapy, support groups, and lifestyle changes.

How Does Vivitrol Naltrexone Injection Work?

Vivitrol contains naltrexone, an opioid antagonist that blocks the mu-opioid receptors in the brain. These receptors are responsible for the pleasurable effects of alcohol and opioids. When these receptors are blocked, the rewarding sensations that typically reinforce substance use are significantly diminished.

For alcohol addiction: Naltrexone reduces the euphoric effects of drinking and can decrease alcohol cravings. Many patients report that alcohol simply becomes less appealing or that the compulsive urge to continue drinking after the first drink is reduced.

For opioid addiction: The injection blocks the effects of opioids completely. If someone taking Vivitrol uses heroin, prescription opioids, or other opioid substances, they will not experience the expected high, making relapse less rewarding and potentially preventing a full return to active addiction.

The extended-release formulation ensures that naltrexone remains active in the system for approximately 30 days. This consistency is crucial because addiction often involves impulsive decisions, and having continuous medication coverage removes the daily choice of whether to take medication.

Who Is a Good Candidate for Vivitrol Treatment?

Vivitrol can be an effective component of comprehensive addiction treatment, but it is not appropriate for everyone. The best candidates typically meet several specific criteria:

Medical Requirements:

Must be completely detoxed from opioids (7-10 days for short-acting opioids, 10-14 days for long-acting opioids like methadone)
No current use of opioid medications for pain management
No severe liver disease or hepatitis
Not pregnant or breastfeeding
No known allergies to naltrexone or polylactide-co-glycolide

Psychological and Social Factors:

Motivated to maintain abstinence from alcohol or opioids
Willing to participate in comprehensive treatment including therapy and support groups
Has social support or family involvement in recovery
History of relapse despite other treatment attempts
Concerns about medication compliance with daily oral medications

Individuals receiving alcohol addiction treatment may find Vivitrol particularly helpful if they struggle with intense cravings or have difficulty stopping after the first drink. The medication works best when combined with behavioral therapies that address the underlying patterns and triggers associated with alcohol use disorder.

What to Expect During Vivitrol Treatment

Initial Assessment and Preparation: Before starting Vivitrol, healthcare providers conduct comprehensive medical and psychiatric evaluations. For individuals with opioid addiction, a naloxone challenge test may be performed to ensure complete detoxification. This involves administering a small dose of naloxone to confirm that opioid withdrawal symptoms do not occur.

The Injection Process: Vivitrol is administered as an intramuscular injection in the gluteal muscle (buttock) once every four weeks. The injection itself takes only a few minutes, but patients typically remain in the clinic for observation for about 30 minutes to monitor for any immediate adverse reactions.

Side Effects and Monitoring: Common side effects include injection site reactions such as pain, swelling, or bruising. Some patients experience nausea, headache, dizziness, or fatigue, particularly during the first few doses. More serious but rare side effects can include severe injection site reactions, liver problems, or allergic reactions.

Ongoing Medical Supervision: Regular follow-up appointments are essential to monitor treatment response, manage side effects, and coordinate with other aspects of recovery programming. Blood tests may be performed periodically to check liver function, especially during the first few months of treatment.

Benefits of Monthly Naltrexone Injections

The extended-release format of Vivitrol offers several advantages over daily oral naltrexone:

Improved Medication Adherence: Research shows that medication compliance is a significant challenge in addiction treatment. The monthly injection eliminates the daily decision about whether to take medication, which is particularly important during periods of high stress or strong cravings.

Consistent Therapeutic Levels: The injection provides steady naltrexone levels throughout the month, avoiding the peaks and valleys associated with daily dosing. This consistency can lead to more stable mood and craving management.

Reduced Treatment Burden: Monthly injections require fewer clinic visits compared to daily medication pickup or frequent check-ins, making treatment more practical for working individuals or those with transportation challenges.

Family Peace of Mind: Loved ones often feel reassured knowing that medication protection is in place for the full month, reducing anxiety about potential relapse and supporting family recovery dynamics.

Support for Treatment Engagement: The monthly clinic visits provide regular opportunities for brief counseling, treatment plan adjustments, and connection with the healthcare team, helping maintain treatment engagement.

Vivitrol in Comprehensive Addiction Treatment

While Vivitrol can be a powerful tool in recovery, it is most effective when integrated into a comprehensive treatment approach. Medication alone does not address the behavioral, psychological, and social aspects of addiction that require attention for long-term recovery.

Therapeutic Integration: Cognitive-behavioral therapy (CBT), motivational interviewing, and other evidence-based therapies help individuals develop coping skills, identify triggers, and modify the thought patterns that contribute to substance use. The protection offered by Vivitrol creates a window of opportunity for these therapeutic interventions to take hold.

Support Group Participation: Many individuals benefit from 12-step programs, SMART Recovery, or other peer support groups while taking Vivitrol. The medication can reduce cravings and impulsive use, making it easier to engage meaningfully in these recovery communities.

Lifestyle and Social Changes: Recovery often requires significant changes in social networks, daily routines, and recreational activities. Vivitrol provides a buffer against impulsive substance use while individuals work to establish new patterns and relationships that support sobriety.

Treatment of Co-occurring Disorders: Many people with addiction also struggle with depression, anxiety, trauma, or other mental health conditions. Addressing these co-occurring disorders through integrated treatment is essential for long-term success, and Vivitrol can provide stability during this complex treatment process.

Cost, Insurance, and Access Considerations

The cost of Vivitrol can be significant, with monthly injections typically ranging from $1,000 to $1,500 without insurance coverage. However, most major insurance plans, including Medicare and Medicaid, provide coverage for FDA-approved addiction medications when medically necessary.

Insurance Coverage Tips:

Prior authorization may be required, often involving documentation of previous treatment attempts or medical necessity
Some plans may require step therapy, starting with oral naltrexone before approving the injection
Appeal processes are available if initial coverage is denied
Patient assistance programs from the manufacturer may help reduce out-of-pocket costs

Access and Availability: Not all healthcare providers are familiar with Vivitrol administration, so finding an experienced clinic or treatment program is important. The medication requires special storage and handling, and staff must be trained in proper injection techniques and emergency procedures.

Important Safety Considerations and Contraindications

Opioid Sensitivity Warning: One of the most critical safety concerns with Vivitrol is that patients may have reduced tolerance to opioids during treatment. If someone taking the injection uses opioids, they may be at increased risk for overdose because their tolerance has decreased while the medication blocked the effects.

Medical Alert Recommendations: Patients should carry medical alert identification indicating they are taking naltrexone. In medical emergencies where opioid pain medication is needed, healthcare providers need to know about Vivitrol treatment to plan appropriate pain management strategies.

Pregnancy and Breastfeeding: The safety of Vivitrol during pregnancy and breastfeeding has not been fully established. Women of childbearing age should discuss contraception and pregnancy planning with their healthcare provider.

Mental Health Monitoring: Some patients may experience mood changes, depression, or suicidal thoughts while taking naltrexone. Regular mental health monitoring and integrated psychiatric care are important components of safe treatment.

Injection Site Care: Proper injection site rotation and post-injection care are important to prevent complications such as infection, abscess formation, or tissue damage.

How Long Should Someone Take Vivitrol?

The optimal duration of Vivitrol treatment varies significantly among individuals and depends on multiple factors including addiction severity, treatment response, social support, and personal recovery goals. Research suggests that longer treatment periods are generally associated with better outcomes.

Typical Treatment Timelines:

Minimum effective treatment: 6 months for most individuals
Standard recommendation: 12 months of continuous treatment
Extended treatment: Some individuals benefit from 18-24 months or longer
Maintenance approach: Ongoing treatment with periodic evaluation for discontinuation readiness

Factors Influencing Treatment Duration:

Stability in recovery and development of strong coping skills
Presence of social support and sober social networks
Resolution of co-occurring mental health conditions
Engagement in ongoing therapy and support groups
Stable housing, employment, and life circumstances
History of previous relapse patterns

Discontinuation of Vivitrol should always be planned collaboratively with the treatment team, with enhanced monitoring and support during the transition period.

Comparing Vivitrol to Other Medication-Assisted Treatment Options

Understanding how Vivitrol compares to other FDA-approved addiction medications can help individuals and families make informed treatment decisions:

Vivitrol vs. Oral Naltrexone: Both contain the same active ingredient, but the injection offers superior compliance and consistent blood levels. Oral naltrexone requires daily administration and has higher discontinuation rates.

Vivitrol vs. Methadone: Methadone is an opioid agonist that prevents withdrawal and cravings but requires daily clinic visits and carries risks of dependence and overdose. Vivitrol is non-addictive but requires complete detoxification before starting.

Vivitrol vs. Buprenorphine: Buprenorphine (Suboxone, Sublocade) is a partial opioid agonist that can be prescribed in office-based settings. It may be easier to start for people not ready for complete opioid cessation, but it carries some risk of misuse.

For Alcohol Addiction: Other FDA-approved medications include acamprosate (Campral) and disulfiram (Antabuse), each with different mechanisms of action and side effect profiles. The choice depends on individual medical history, treatment goals, and patient preferences.

Success Rates and Clinical Evidence

Clinical trials have demonstrated the effectiveness of vivitrol naltrexone injection for both alcohol and opioid addiction, though success rates vary depending on how outcomes are measured and what supportive treatments are provided.

Alcohol Use Disorder Studies: Research shows that Vivitrol can reduce heavy drinking days by 25-30% compared to placebo when combined with behavioral interventions. The medication is particularly effective for individuals who have already achieved initial sobriety and want to maintain abstinence.

Opioid Addiction Research: Studies demonstrate that Vivitrol can help maintain abstinence from opioids and reduce relapse rates when patients are able to complete the initial detoxification period successfully. The challenge is often getting through detox and starting the first injection.

Real-World Effectiveness: Clinical trial results may not fully reflect real-world outcomes because study participants often receive more intensive support services than typical patients. Success with Vivitrol is strongly influenced by the comprehensiveness of the overall treatment program and the individual’s readiness for change.

Most addiction medicine specialists emphasize that medication is most effective when viewed as one component of a comprehensive recovery plan rather than a standalone solution.

Take the Next Step Toward Recovery

If you or someone you care about is struggling with substance use, a professional assessment can clarify the right level of care and create a path forward.

Lighthouse provides evidence-based treatment for men prepared to build a foundation for long-term recovery. Our programs include Partial Hospitalization (PHP), Intensive Outpatient (IOP), and Extended Care Treatment, all designed with small group sizes, individualized care, high accountability, and integrated psychiatric support where needed. Please call us at (214) 717-5884, verify your insurance to understand your coverage options, or take a short online assessment to get started.